Detailed Information on Publication Record
2018
Reprogramming of peripheral blood cells into hiPSCs as a source of endothelial cells
ŠIMARA, Pavel, Lenka TESAŘOVÁ, Daniela ŘEHÁKOVÁ, Šimon FARKAŠ, Barbara ŠALINGOVÁ et. al.Basic information
Original name
Reprogramming of peripheral blood cells into hiPSCs as a source of endothelial cells
Authors
ŠIMARA, Pavel, Lenka TESAŘOVÁ, Daniela ŘEHÁKOVÁ, Šimon FARKAŠ, Barbara ŠALINGOVÁ, Kateřina KUTÁLKOVÁ, Eva VAVREČKOVÁ, Pavel MATULA, Petr MATULA and Irena KRONTORÁD KOUTNÁ
Edition
SY-Stem symposium 2018, 2018
Other information
Language
English
Type of outcome
Konferenční abstrakt
Field of Study
10601 Cell biology
Country of publisher
Austria
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Organization unit
Faculty of Informatics
Keywords (in Czech)
buněčná reprogramace, endotheliální diferenciace
Keywords in English
cellular reprogramming, endothelial differentiation
Změněno: 2/3/2018 10:41, Mgr. Pavel Šimara, Ph.D.
Abstract
V originále
Recent advances in human induced pluripotent stem cell (hiPSC) research have opened avenues to generate unlimited numbers of endothelial cells (ECs) from easily accessible cell sources, such as the peripheral blood. We reprogrammed peripheral blood mononuclear cells (PBMCs), human umbilical vein endothelial cells (HUVECs) and human saphenous vein endothelial cells (HSVECs) into hiPSCs and differentiated them into ECs. hiPSC-derived ECs were compared to HUVECs and HSVECs. hiPSC-derived ECs resembled their natural EC counterparts both phenotypically and functionally. An increased number of DNA double-strand breaks (γH2AX) upon reprogramming was observed. However, differentiation into ECs restored a normal number of γH2AX foci. Peripheral blood from adult donors is a suitable source for the unlimited production of patient-specific ECs through the hiPSC interstage.
Links
GBP302/12/G157, research and development project |
| ||
NV16-31501A, research and development project |
|